Enable job alerts via email!
Boost your interview chances
Create a job specific, tailored resume for higher success rate.
A leading research hospital in Canada seeks a Senior Scientist I for the Peter Gilgan Chair in Neuroregeneration Research. This role involves developing innovative research strategies, leading a high-caliber research program, and collaborating with top professionals in the field. The successful candidate will be expected to teach and demonstrate outstanding research leadership while contributing to the advancement of neuroregeneration research. A competitive salary and benefits package, including relocation support, will be offered.
UHN is Canada’s #1 hospital and the world’s #1 publicly funded hospital. With 10 sites and more than 44,000 TeamUHN members, UHN consists of Toronto General Hospital, Toronto Western Hospital, Princess Margaret Cancer Centre, Toronto Rehabilitation Institute, The Michener Institute of Education and West Park Healthcare Centre. As Canada's top research hospital, the scope of biomedical research and complexity of cases at UHN have made it a national and international source for discovery, education and patient care. UHN has the largest hospital-based research program in Canada, with major research in neurosciences, cardiology, transplantation, oncology, surgical innovation, infectious diseases, genomic medicine and rehabilitation medicine. UHN is a research hospital affiliated with the University of Toronto.
UHN’s vision is to build A Healthier World, and it’s only because of the talented and dedicated people who work here that we are continually bringing that vision closer to reality.
The Krembil Brain Institute at University Health Network (UHN), a University of Toronto (U of T) teaching hospital, is seeking applicants for the inaugural Peter Gilgan Chair in Neuroregeneration Research. The successful candidate must already hold, or be eligible for, a full-time clinical or status-only academic appointment within the Temerty Faculty of Medicine, U of T, at the rank of Associate or Full Professor. The term of the Chair position is 5 years with the opportunity for one 5-year renewal following a successful review. The position will begin at a mutually agreeable time.
The Peter Gilgan Chair in Neuroregeneration Research will develop and lead research supporting multidisciplinary strategies to promote neuroregeneration in preclinical models with the goal of translating bench research to bedside impact. The role involves active leadership, nationally and internationally, to advance research strategies for neuroregeneration. The Chairholder will integrate, build, and strengthen the Institute’s efforts, and champion collaborative and integrative research to build bridges between the Krembil Brain Institute at UHN, U of T, and other TAHSN hospitals. The Chairholder will collaborate with clinicians and researchers at the Krembil Brain Institute.
Salary will be commensurate with qualifications and experience. A competitive benefits package is offered along with support for relocation expenses.
Duties
UHN offers a wide range of benefits and perks, including competitive packages, pension plan, transit access, flexible work environment, development opportunities, and various discounts.
Current UHN employees must have completed probation and have a satisfactory record to be eligible.
All applications must be submitted before the closing date. UHN communicates via email. A Criminal Record Check may be required. Misleading or inaccurate information may result in application discontinuation.
UHN is committed to diversity and inclusion. Requests for accommodations can be made at any stage of the process.
We thank all applicants for their interest; only those selected for further consideration will be contacted.